Science Explorer Back to mapMap
Discussion
Company · Brno · Czechia

BioVendor (Czechia)

biovendor.czROR OpenAlex
Research works
16
▼ 45% vs 2018-21
Citations
279
17.4 per fractional work
Top-10% rate
4.1%
all institutions 10.0%
Open access
47%
world 40%
International
26%
world 18%
BioVendor (Czechia)

Not ranked overall: BioVendor (Czechia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does BioVendor (Czechia) work in?

In all years, 49% of research at BioVendor (Czechia) is in Life Sciences, 43% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (40%), Medicine (40%), Neuroscience (5%). It does 2.0× the world's share of Life Sciences.

Life Sciences: 8 fractional works · 48.8% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 40.2% of its workMolecular Biology: 4 fractional works · 22.1% of its workCancer Research: 2 fractional works · 11.9% of its workBiochemistry: 0 fractional works · 2.6% of its workGenetics: 0 fractional works · 2.2% of its workClinical Biochemistry: 0 fractional works · 1.1% of its workBiotechnology: 0 fractional works · 0.3% of its workNeuroscience: 1 fractional works · 5.3% of its workBiological Psychiatry: 0 fractional works · 2.1% of its workNeurology: 0 fractional works · 1.3% of its workEndocrine and Autonomic Systems: 0 fractional works · 1.2% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 0 fractional works · 2.1% of its workImmunology: 0 fractional works · 1.1% of its workMicrobiology: 0 fractional works · 1.1% of its workAgricultural and Biological Sciences: 0 fractional works · 1.2% of its workAnimal Science and Zoology: 0 fractional works · 0.7% of its workInsect Science: 0 fractional works · 0.5% of its workHealth Sciences: 7 fractional works · 43.2% of its workMedicine: 6 fractional works · 39.7% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 7.1% of its workEpidemiology: 1 fractional works · 5.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 4.1% of its workPhysiology: 1 fractional works · 3.6% of its workOncology: 0 fractional works · 2.9% of its workPulmonary and Respiratory Medicine: 0 fractional works · 2.6% of its workSurgery: 0 fractional works · 2.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 2.2% of its workPsychiatry and Mental health: 0 fractional works · 1.8% of its workPathology and Forensic Medicine: 0 fractional works · 1.2% of its workImmunology and Allergy: 0 fractional works · 1.1% of its workNephrology: 0 fractional works · 1.0% of its workPharmacology: 0 fractional works · 0.9% of its workHematology: 0 fractional works · 0.7% of its workInfectious Diseases: 0 fractional works · 0.7% of its workInternal Medicine: 0 fractional works · 0.7% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.7% of its workDentistry: 0 fractional works · 2.9% of its workPeriodontics: 0 fractional works · 2.6% of its workOral Surgery: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 0.7% of its workEmergency Medical Services: 0 fractional works · 0.7% of its workPhysical Sciences: 1 fractional works · 5.9% of its workEngineering: 0 fractional works · 2.9% of its workBiomedical Engineering: 0 fractional works · 2.9% of its workChemistry: 0 fractional works · 2.2% of its workSpectroscopy: 0 fractional works · 2.2% of its workMaterials Science: 0 fractional works · 0.7% of its workBiomaterials: 0 fractional works · 0.7% of its workSocial Sciences: 0 fractional works · 2.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 2.1% of its workEconomics and Econometrics: 0 fractional works · 1.4% of its workGeneral Economics, Econometrics and Finance: 0 fractional works · 0.7% of its workALL ITS WORKBioVendor(Czechia)16fractional works, all years
Life Sciences49%Physical Sciences6%Health Sciences43%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology640.2%
    2. Neuroscience15.3%
    3. Immunology and Microbiology02.1%
    4. Agricultural and Biological Sciences01.2%
    1. Medicine639.7%
    2. Dentistry02.9%
    3. Health Professions00.7%
    1. Engineering02.9%
    2. Chemistry02.2%
    3. Materials Science00.7%
    1. Economics, Econometrics and Finance02.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.52× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 2.05× its world share, 0 worksImmunology and Micro…Neuroscience: 4.73× its world share, 0 worksNeuroscienceEngineering: 0.47× its world share, 0 worksEngineeringMaterials Science: 1.18× its world share, 0 worksMaterials ScienceDentistry: 8.51× its world share, 0 worksDentistryHealth Professions: 1.57× its world share, 0 worksHealth ProfessionsMedicine: 1.79× its world share, 1 worksMedicineEconomics, Econometrics and Finance: 5.79× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Dentistry, 8.5×. Every wedge is a field page.

All 9 fields, with their numbers
  1. Dentistry8.51×0 works
  2. Economics, Econometrics and Finance5.79×0 works
  3. Neuroscience4.73×0 works
  4. Biochemistry, Genetics and Molecular Biology4.52×1 works
  5. Immunology and Microbiology2.05×0 works
  6. Medicine1.79×1 works
  7. Health Professions1.57×0 works
  8. Materials Science1.18×0 works
  9. Engineering0.47×0 works

Who are the top researchers at BioVendor (Czechia)?

Ranked on the quality score, Viktor Růžička and Lenka Chalupová lead among researchers whose main affiliation is BioVendor (Czechia).

  1. 1 Viktor Růžička Czechia · #3,573,518 worldwide 594 citations · 25 works
  2. 2 Lenka Chalupová Czechia · #4,287,234 worldwide 104 citations · 16 works
All ranked researchers at BioVendor (Czechia)

What are the most cited papers from BioVendor (Czechia)?

The most cited paper from BioVendor (Czechia) is "Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor‐21 in patients with type 2 diabetes and obesity" (Miloš Mráz, Markéta Bártlová, Z Lacinová et al., 2008), with 283 citations. Next come "Validation and verification of predictive salivary biomarkers for oral health" (66) and "Salivary Biomarkers for Dental Caries Detection and Personalized Monitoring" (58).

Most cited papers
#PaperReleasedCitations
1 Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor‐21 in patients with type 2 diabetes and obesity Miloš Mráz, Markéta Bártlová, Z Lacinová et al. · Clinical Endocrinology 11 Dec 2008 283
2 Validation and verification of predictive salivary biomarkers for oral health Nagihan Bostancı, Konstantinos Mitsakakis, Beral Afacan et al. · Scientific Reports Open access 19 Mar 2021 66
3 Salivary Biomarkers for Dental Caries Detection and Personalized Monitoring Pune Nina Paqué, Christopher Herz, Daniel B. Wiedemeier et al. · Journal of Personalized Medicine Open access 23 Mar 2021 58
4 PCR-RFLP detection and species identification of fungal pathogens in patients with febrile neutropenia Miloš Dendis, Robert L. Horvath, Jaroslav Michálek et al. · Clinical Microbiology and Infection Open access Dec 2003 56
5 Development of a novel enzyme-linked immunosorbent assay (ELISA) for measurement of serum CTRP1 Lenka Chalupová, A. Zakovska, K. ADAMCOVÁ · Clinical Biochemistry 19 Sep 2012 47
All 55 most cited papers, with filters and sorting

Which research topics does BioVendor (Czechia) publish most on?

By volume in 2022-now: MicroRNA in disease regulation, Blood properties and coagulation, Tryptophan and brain disorders and Monetary Policy and Economic Impact.

MicroRNA in disease regu…0MicroRNA in disease regulation: 0 fractional worksBlood properties and coa…0Blood properties and coagulation: 0 fractional worksTryptophan and brain dis…0Tryptophan and brain disorders: 0 fractional worksMonetary Policy and Econ…0Monetary Policy and Economic Impact: 0 fractional worksVenous Thromboembolism Diagnosis and Management: 0 fractional worksEconomic Growth and Productivity: 0 fractional worksElectrospun Nanofibers i…0Electrospun Nanofibers in Biomedical Applications: 0 fractional worksNeonatal and Maternal Infections: 0 fractional worksCircular RNAs in diseases: 0 fractional worksPediatric health and res…0Pediatric health and respiratory diseases: 0 fractional works
Cancer ResearchPulmonary and Respiratory MedicineBiological PsychiatryGeneral Economics, Econometrics and Finance6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 MicroRNA in disease regulation Cancer Research 0 works
  2. 2 Blood properties and coagulation Pulmonary and Respiratory Medicine 0 works
  3. 3 Tryptophan and brain disorders Biological Psychiatry 0 works
  4. 4 Monetary Policy and Economic Impact General Economics, Econometrics and Finance 0 works
  5. 5 Venous Thromboembolism Diagnosis and Management Internal Medicine 0 works
  6. 6 Economic Growth and Productivity Economics and Econometrics 0 works
  7. 7 Electrospun Nanofibers in Biomedical Applications Biomaterials 0 works
  8. 8 Neonatal and Maternal Infections Public Health, Environmental and Occupational Health 0 works
  9. 9 Circular RNAs in diseases Molecular Biology 0 works
  10. 10 Pediatric health and respiratory diseases Emergency Medical Services 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.3%not open52.7%

World: 40% of research is openly available.

with international co-authors26.2%domestic only73.8%

World: 18% is written across borders.

How has BioVendor (Czechia)'s research output changed?

Output in 2022-2025 was 45% lower than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is BioVendor (Czechia) as a percentage of every work published that year, 0.000022% in 2024.

still counting0.000025%0.000050%0.000075%BioVendor (Czechia)0.0000056% in 2025200020102020

Fractional works of BioVendor (Czechia) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Brno

All research institutions in Brno

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about BioVendor (Czechia). Posts are plain text and can be reported.